Can you provide a specific patient example -- in a patient with EGFR-positive NSCLC -- where ctDNA may redirect treatment?

Can you provide a specific patient example -- in a patient with EGFR-positive NSCLC -- where ctDNA may redirect treatment?

Can you provide a specific patient example — in a patient with EGFR-positive NSCLC — where ctDNA may redirect treatment?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Razelle Kurzrock, MD

Razelle Kurzrock, MD

Chief, Division of Hematology and Oncology
UCSD School of Medicine
Senior Deputy Director, Clinical Science
Director, Center for Personalized Cancer Therapy
Director, Clinical Trials Office
UCSD Moores Cancer Center
San Diego, California